Physician profile
Jan O Sonander
NPI 1982763959
$1,144.46
in general payments reported to CMS, 2019-2025
11 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.29 · 2020: $13.33 · 2021: $100 · 2022: $89.67 · 2023: $649 · 2024: $83.31 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $466.09 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Glaxosmithkline, LLC. | $190.41 | 2021-2023 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $159.24 | 2023-2025 | Ozempic, Rybelsus |
| Amgen INC. | $113.11 | 2023-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $56.77 | 2019-2021 | |
| Lilly USA, LLC | $48.33 | 2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $40.90 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $25.03 | 2022 | |
| Allergan, INC. | $18.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.96 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Sonander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.